114 related articles for article (PubMed ID: 29511446)
1. NudCD1 affects renal cell carcinoma through regulating LIS1/Dynein signaling pathway.
He H; Dai J; Wang X; Qian X; Zhao J; Wang H; Xu D
Am J Transl Res; 2018; 10(2):519-524. PubMed ID: 29511446
[TBL] [Abstract][Full Text] [Related]
2. The impact of NudCD1 on renal carcinoma cell proliferation, migration, and invasion.
Wang RJ; Wang N; Cui G; Chen Y; Zhong H; Tang J
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):671-677. PubMed ID: 29461594
[TBL] [Abstract][Full Text] [Related]
3. NudCD1 as a prognostic marker in colorectal cancer and its role in the upregulation of cellular spindle assembly checkpoint genes and LIS1 pathways.
Feng WM; Gong H; Wang YC; Wang Y; Xue T; Zhang T; Cui G
BMC Cancer; 2022 Sep; 22(1):981. PubMed ID: 36104662
[TBL] [Abstract][Full Text] [Related]
4. NUDCD1 promotes metastasis through inducing EMT and inhibiting apoptosis in colorectal cancer.
Han B; Zhang YY; Xu K; Bai Y; Wan LH; Miao SK; Zhang KX; Zhang HW; Liu Y; Zhou LM
Am J Cancer Res; 2018; 8(5):810-823. PubMed ID: 29888104
[TBL] [Abstract][Full Text] [Related]
5. NudC associates with Lis1 and the dynein motor at the leading pole of neurons.
Aumais JP; Tunstead JR; McNeil RS; Schaar BT; McConnell SK; Lin SH; Clark GD; Yu-Lee LY
J Neurosci; 2001 Dec; 21(24):RC187. PubMed ID: 11734602
[TBL] [Abstract][Full Text] [Related]
6. A unique role of dynein and nud family proteins in corticogenesis.
Toba S; Hirotsune S
Neuropathology; 2012 Aug; 32(4):432-9. PubMed ID: 22393875
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of NudC family: from molecular regulation to clinical implications.
Fu Q; Wang W; Zhou T; Yang Y
Sci China Life Sci; 2016 May; 59(5):455-62. PubMed ID: 26965524
[TBL] [Abstract][Full Text] [Related]
8. The lissencephaly protein Lis1 is present in motile mammalian cilia and requires outer arm dynein for targeting to Chlamydomonas flagella.
Pedersen LB; Rompolas P; Christensen ST; Rosenbaum JL; King SM
J Cell Sci; 2007 Mar; 120(Pt 5):858-67. PubMed ID: 17314247
[TBL] [Abstract][Full Text] [Related]
9. Identifying the role of NUDCD1 in human tumors from clinical and molecular mechanisms: a study based on comprehensive bioinformatics and experimental validation.
Han B; He J; Chen Q; Yuan M; Zeng X; Li Y; Zeng Y; He M; Feng D; Ma D
Aging (Albany NY); 2023 Jun; 15(12):5611-5649. PubMed ID: 37338527
[TBL] [Abstract][Full Text] [Related]
10. NudC regulated Lis1 stability is essential for the maintenance of dynamic microtubule ends in axon terminals.
Kawano D; Pinter K; Chlebowski M; Petralia RS; Wang YX; Nechiporuk AV; Drerup CM
iScience; 2022 Oct; 25(10):105072. PubMed ID: 36147950
[TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanism of lissencephaly--how LIS1 and NDEL1 regulate cytoplasmic dynein?].
Hirotsune S
Brain Nerve; 2008 Apr; 60(4):375-81. PubMed ID: 18421979
[TBL] [Abstract][Full Text] [Related]
12. Role of dynein, dynactin, and CLIP-170 interactions in LIS1 kinetochore function.
Tai CY; Dujardin DL; Faulkner NE; Vallee RB
J Cell Biol; 2002 Mar; 156(6):959-68. PubMed ID: 11889140
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of LIS1, dynein and their interaction partners dynactin, NudE, NudEL and NudC in human gliomas suggest roles in invasion and proliferation.
Suzuki SO; McKenney RJ; Mawatari SY; Mizuguchi M; Mikami A; Iwaki T; Goldman JE; Canoll P; Vallee RB
Acta Neuropathol; 2007 May; 113(5):591-9. PubMed ID: 17221205
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cytoplasmic dynein ATPase by Lis1.
Mesngon MT; Tarricone C; Hebbar S; Guillotte AM; Schmitt EW; Lanier L; Musacchio A; King SJ; Smith DS
J Neurosci; 2006 Feb; 26(7):2132-9. PubMed ID: 16481446
[TBL] [Abstract][Full Text] [Related]
15. Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning.
Shu T; Ayala R; Nguyen MD; Xie Z; Gleeson JG; Tsai LH
Neuron; 2004 Oct; 44(2):263-77. PubMed ID: 15473966
[TBL] [Abstract][Full Text] [Related]
16. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
17. HDAC7 inhibits cell proliferation via NudCD1/GGH axis in triple-negative breast cancer.
Zhu M; Liu N; Lin J; Wang J; Lai H; Liu Y
Oncol Lett; 2023 Jan; 25(1):33. PubMed ID: 36589669
[TBL] [Abstract][Full Text] [Related]
18. Lis1 Has Two Opposing Modes of Regulating Cytoplasmic Dynein.
DeSantis ME; Cianfrocco MA; Htet ZM; Tran PT; Reck-Peterson SL; Leschziner AE
Cell; 2017 Sep; 170(6):1197-1208.e12. PubMed ID: 28886386
[TBL] [Abstract][Full Text] [Related]
19. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
